NCT06496204

Brief Summary

Aging means loss of strength, which can affect the ability to lead an active life and be independent. Physical activity can counteract the loss of strength to some extent, but individual differences are large and the mechanisms are partly unknown. The hypothesis is that changes in the innervation and composition of the muscle may explain the individual differences in strength loss. A group of Swedish men and women have participated in this study of physical performance for almost 50 years, since they were 16 years old. The project will improve the understanding of muscle aging. The findings may help to develop strategies to counteract muscle loss and enable healthy aging and to promote physical activity throughout life

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
429

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 11, 2024

Completed
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

1.2 years

First QC Date

May 27, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

physical fitnessaerobic capacityskeletal muscleneuromuscular junctionmotor unitageinglongitudinal studyimmunohistochemistryUPS system

Outcome Measures

Primary Outcomes (4)

  • Aerobic capacity

    Submaximal ergometer test estimating maximal oxygen consumption (L/min)

    through study completion, an average of 70 year

  • Skeletal muscle fiber distribution

    Proportion of type I and type II skeletal muscle fibers from biopsies

    through study completion, an average of 70 year

  • Sargent Jump

    Vertical jump (cm)

    through study completion, an average of 70 year

  • Muscular endurance

    Bench press test with women lifting 12 kg and med 20 kg at a pace of 25 lifts per minute until exhaustion

    through study completion, an average of 70 year

Secondary Outcomes (2)

  • physical activity

    through study completion, an average of 70 year

  • Educational level

    through study completion, an average of 70 year

Study Arms (1)

SPAF

At the beginning of the study, in 1974, a group of 429 (224 males, and 205 females) of pupils at secondary high school in Sweden was systematically selected: The country was stratified into six regions with a similar population size and climate. In each region, one or more secondary high schools were randomly selected. At each school, the number of pupils was selected in proportion to the distribution of girls and boys in secondary high school, the number of pupils in the region, and the proportion of pupils in each school program (theoretical three-year program to prepare for higher studies or practical two-year program to prepare for working life). Individual subjects were then randomly selected at each school based on these criteria and are representative of 16-year-old girls and boys attending secondary high school in Sweden. All participants have been invited to followups at age 34, 52 and 63 years

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

se above

You may qualify if:

  • Belonging to the 0.5% of all pupils who entered secondary high school in Sweden in 1974 and attended one of the systematically selected secondary high schools, and was belonging to the systematically selected pupils.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska institutet

Stockholm, 14152, Sweden

Location

Related Publications (1)

  • Westerstahl M, Jornaker G, Jansson E, Aasa U, Ingre M, Pourhamidi K, Ulfhake B, Gustafsson T. Rise and Fall of Physical Capacity in a General Population: A 47-Year Longitudinal Study. J Cachexia Sarcopenia Muscle. 2025 Dec;16(6):e70134. doi: 10.1002/jcsm.70134.

Biospecimen

Retention: SAMPLES WITH DNA

Blood, muscle tissue, skin tissue

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 27, 2024

First Posted

July 11, 2024

Study Start

March 22, 2021

Primary Completion

June 8, 2022

Study Completion

June 8, 2022

Last Updated

April 2, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Publication data can be shared

Locations